Last reviewed · How we verify

NCT05731778

Clinical Study to Assess Therapeutic Delay and Resolution of Induced Gingivitis

Completed Phase 4 Last updated 16 February 2023
What this trial tests

Phase 4 trial testing Stannous Fluoride Toothpaste in Gingivitis in 26 participants. Completed in 22 December 2020.

Timeline
22 December 2018
Primary endpoint
22 December 2020
22 December 2020

Quick facts

Lead sponsorColgate Palmolive
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment26
Start date22 December 2018
Primary completion22 December 2020
Estimated completion22 December 2020
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Colgate Palmolive — full company profile →

Who can join

Adults 18 to 70, any sex, with Gingivitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate a stannous technology for its effect on the neutrophil phenotype during an induced gingivitis state.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Gingivitis

Currently open trials in the same condition.

Other Colgate Palmolive trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05731778.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing